
The global medical marijuana market is rapidly growing, expected to reach over $130 billion by the early to mid-2030s due to expanding legalization, increased clinical adoption, and rising demand for non-opioid treatments. Companies like Herbal Dispatch, High Tide, and Trulieve are capitalizing on this trend with innovative services, including veteran-focused channels and insurance-supported care. Regulatory changes, such as the DEA's rescheduling of medical cannabis to Schedule III, are facilitating faster market growth and institutional investment. This momentum positions medical cannabis as a significant player in global healthcare and life sciences moving forward.